PESCIA, CARLO
PESCIA, CARLO
Universita' degli Studi di MILANO
Clinical and prognostic correlates of the reticulin-collagen-osteosclerosis score in primary myelofibrosis
2025 R. Santi, G. Coltro, G. Di Stefano, A. Atanasio, P. Cicogna, G. Loscocco, G. Capecchi, V. Boldrini, C. Pescia, P. Guglielmelli, A. Vannucchi, U. Gianelli
Three-Month cART Initiated During Primary HIV Does Not Correct the Structural, Immune, and Microbial Abnormalities within the Gastrointestinal Tract
2025 C. Tincati, V. Bono, S. Nozza, A. Bandera, D. Tosi, V. Sala, G. Ancona, A. Calcagno, A. Muscatello, S. Rusconi, M. Augello, R. Rovito, U. Gianelli, C. Pescia, A. Santoro, M. Falleni, A. Gori, G. Marchetti
Prognostic impact of tumor-infiltrating lymphocytes in HER2+ metastatic breast cancer receiving first-line treatment
2025 B. Taurelli Salimbeni, F. Giudici, C. Pescia, P.P.M. Berton Giachetti, R. Scafetta, P. Zagami, A. Marra, D. Trapani, A. Esposito, S. Scagnoli, B. Cerbelli, A. Botticelli, E. Munzone, N. Fusco, C. Criscitiello, G. Curigliano
Is atypical parathyroid tumor a different clinical entity than parathyroid adenoma and carcinoma? A retrospective review of a large single-center case series
2025 C. Maconi, A.M. Saibene, L. Castellani, P. Lozza, C. Pescia, M. Falleni, L. De Pasquale
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
2024 M. Ivanova, F.M. Porta, M. D'Ercole, C. Pescia, E. Sajjadi, G. Cursano, E. De Camilli, O. Pala, G. Mazzarol, K. Venetis, E. Guerini-Rocco, G. Curigliano, G. Viale, N. Fusco
Immune and Gene-expression Profiling in Estrogen Receptor Low and Negative Early Breast Cancer
2024 D. Massa, C. Vernieri, L. Nicolè, C. Criscitiello, F. Boissière-Michot, S. Guiu, A. Bobrie, G. Griguolo, F. Miglietta, A. Vingiani, R. Lobefaro, B. Taurelli Salimbeni, C. Pinato, F. Schiavi, S. Brich, C. Pescia, N. Fusco, G. Pruneri, M. Fassan, G. Curigliano, V. Guarneri, W. Jacot, M.V. Dieci
The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective
2024 C. Pescia, G. Lopez, D. Cattaneo, C. Bucelli, U. Gianelli, A. Iurlo
The unexpected guest: Cytotoxic, pseudolymphoma-like reaction at the site of primary cutaneous follicle centre B-cell lymphoma in a patient receiving secukinumab for psoriasis
2024 C. Pescia, G. Pini, S. Tabano, E. Berti, S. Alberti Violetti, G.A. Croci
The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy
2024 K. Venetis, C. Pescia, G. Cursano, C. Frascarelli, E. Mane, E. De Camilli, E. Munzone, S. Dellapasqua, C. Criscitiello, G. Curigliano, E. Guerini Rocco, N. Fusco
Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
2024 M. Ivanova, C. Pescia, D. Trapani, K. Venetis, C. Frascarelli, E. Mane, G. Cursano, E. Sajjadi, C. Scatena, B. Cerbelli, G. D'Amati, F.M. Porta, E. Guerini-Rocco, C. Criscitiello, G. Curigliano, N. Fusco
Wait and see: a case of EBV + cutaneous extranodal NK/T-type lymphoma with indolent behaviour
2023 I.F. Aromolo, C. Pescia, D. Simeoli, S.A. Violetti, V. Ferla, F.G. Rossi, G.A. Croci
A Rare Case of Urinary Bladder Hamartoma Clinically Mimicking an Urothelial Carcinoma: A Case Report and Review of the Literature
2023 C. Pescia, G. Pini, G. Lopez, M. Malfatto, G. Brescia, S. Tabano, A. Del Gobbo
TIGIT in Lung Cancer: Potential Theranostic Implications
2023 C. Pescia, G. Pini, E. Olmeda, S. Ferrero, G. Lopez
Granular cell tumor of the neurohypophysis presenting as a third ventricle mass
2023 G. Lopez, C. Pescia, C. Galli, M. Bramerio, A. Tosoni, M. Nebuloni, M. Ferrara, G. Bertani, L. Caschera, F.M. Triulzi, M. Locatelli, S. Tabano, G.A. Croci
The CDK4/6 inhibitors biomarker landscape: The most relevant biomarkers of response or resistance for further research and potential clinical utility
2023 G. Antonarelli, B. Taurelli Salimbeni, A. Marra, A. Esposito, M.A. Locatelli, D. Trapani, C. Pescia, N. Fusco, G. Curigliano, C. Criscitiello
Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testing
2023 A. Ranghiero, C. Frascarelli, G. Cursano, C. Pescia, M. Ivanova, D. Vacirca, A. Rappa, S.V. Taormina, M. Barberis, N. Fusco, E.G. Rocco, K. Venetis
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing
2023 K. Venetis, F. Pepe, C. Pescia, G. Cursano, C. Criscitiello, C. Frascarelli, E. Mane, G. Russo, B. Taurelli Salimbeni, G. Troncone, E. Guerini Rocco, G. Curigliano, N. Fusco, U. Malapelle
Thymic Epithelial Tumors: An Evolving Field
2023 E. Kuhn, C. Pescia, P. Mendogni, M. Nosotti, S. Ferrero
Advances in Early Breast Cancer Risk Profiling: From Histopathology to Molecular Technologies
2023 C. Pescia, E. Guerini-Rocco, G. Viale, N. Fusco
Fibroblastic/cytokeratin-positive interstitial reticular cell tumor of the spleen with indolent behavior: a case report with review of the literature.
2022 C. Pescia, G. Lopez, U. Gianelli, G. Croci